These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7629560)

  • 1. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.
    Cazzola M; Matera MG; Tufano MA; Polverino M; Catalanotti P; Varanese L; Rossi F
    Pulm Pharmacol; 1994 Dec; 7(6):377-81. PubMed ID: 7549225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis.
    Thompson AB; Bohling T; Payvandi F; Rennard SI
    J Lab Clin Med; 1990 Feb; 115(2):148-58. PubMed ID: 2299262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of cefaclor into bronchial mucosa.
    Marlin GE; Nicholls AJ; Funnell GR; Bradbury R
    Thorax; 1984 Nov; 39(11):813-7. PubMed ID: 6505987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
    Friis C
    Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The penetration of cefpirome into the potential sites of pulmonary infection.
    Baldwin DR; Maxwell SR; Honeybourne D; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1991 Jul; 28(1):79-86. PubMed ID: 1769946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
    Cazzola M; Matera MG; Tufano MA; Catalanotti P; Polverino M; Cantoni V; Fici F; Sarlo F; Rossi F
    J Chemother; 2001 Aug; 13(4):407-12. PubMed ID: 11589484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
    Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
    Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
    Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
    J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
    Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
    Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
    J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
    Matera MG; Tufano MA; Polverino M; Rossi F; Cazzola M
    Eur Respir J; 1997 Jan; 10(1):98-103. PubMed ID: 9032500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung concentrations of telithromycin after oral dosing.
    Khair OA; Andrews JM; Honeybourne D; Jevons G; Vacheron F; Wise R
    J Antimicrob Chemother; 2001 Jun; 47(6):837-40. PubMed ID: 11389116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
    Wise R
    Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The comparative pharmacokinetics of ceftriaxone in the blood and bronchial secretion in patients with different durations in the course of chronic bronchitis].
    Kamnev IuV; Manuĭlov KK; Orlov VA
    Antibiot Khimioter; 1991 Jun; 36(6):48-50. PubMed ID: 1898191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of cefuroxime and ceftazidime into human lungs.
    Perea EJ; Ayarra J; García Iglesias MC; García Luque I; Loscertales J
    Chemotherapy; 1988; 34(1):1-7. PubMed ID: 3280266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.